James McClory

James McClory is a Senior Computational Biologist at LabGenius since December 2022, contributing to innovative antibody discovery using synthetic biology, robotic automation, and machine learning for developing therapeutics targeting solid tumors. Prior to this role, James led antibody engineering efforts at Fusion Antibodies from September 2018 to December 2022, successfully overseeing projects that culminated in the patenting of novel antibody molecules. James began a career in research as a PhD researcher at Queen's University Belfast, where from September 2014 to September 2018, expertise was developed in Computational Chemistry, focusing on molecular dynamics and enzyme mechanisms for drug enhancement and biofuels. James holds a PhD in Computational Chemistry and a Master of Science in Chemistry from Queen's University Belfast.